F00B3C3CDEF4EF9D8725881B006CAA3B Hearing Summary

Representatives Robert and McKean, prime sponsors, presented House Bill 22-1321, concerning a study of devices that are based on FDA-cleared technology capable of self-assessing impairment of motorists to detect the presence of drugs other than alcohol during roadside sobriety investigations. Representative Roberts explained the effect of the bill and discussed its need. Representative McKean provided further input on the merits of the legislation. Representative McKean responded to questions regarding how devices referenced in the bill will help determine marijuana intoxication. Representatives Roberts and McKean responded to questions regarding the reasons for commissioning a study under the bill.

Glen Davis, representing the Department of Transportation, testified in support of HB 22-1321.

Bia Campbell, representing VS Strategies, testified in support of the bill.

Mike Honn, representing the Colorado State Patrol, testified in support of the bill. Ms. Campbell responded to questions regarding how many drug-detecting devices will be subject to study under the bill, how such devices work, and the baseline for cognitive functioning used by these technologies. Discussion ensued regarding privacy concerns with the study commissioned by the bill, and the cost for the study. Discussion followed regarding whether the company charged with conducting the study has already been determined.

Kristin Weber, representing Cognivue, testified in support of HB 22-1321.

Frank Conrad, representing Colorado Green Labs, testified in support of the bill.

Truman Bradley, representing the Marijuana Industry Group, testified in support of the bill.

Mr. Conrad responded to questions regarding demographic diversity among the subjects of the study commissioned by the bill. He also addressed privacy-related questions raised during earlier testimony.

Representative Roberts explained the effect of amendment L.001 (Attachment C). Representative McKean responded to questions regarding the devices to be included in the scope of the study commissioned by HB 22-1321.

Representatives McKean and Roberts provided closing remarks in support of HB 22-1321. Various committee members provided their positions on the bill.